594 participants
A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-13
- Start Date:
- 2022-09-15
- Completion:
- 2025-10-06
Conditions
- Advanced or Metastatic Non-Small Cell Lung Cancer
Interventions
- DRUG
No Results Yet